Back to search
A phase II study of cisplatin (P) plus etoposide (E) plus bevacizumab (B) for previously untreated extensive stage small cell lung cancer (SCLC) (E3501): A trial of the Eastern Cooperative Oncology Group
Data up to Jan 2025
Published2007
Citations39
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database